Authors: DENEKE J LUCKOW V GUSERLE R PASSLER HH

Citation: J. Deneke et al., TRANSSYNOVIAL KINETICS OF IONAZOLAC AND ITS HYDROXY METABOLITE IN SYNOVITIS PATIENTS, International journal of clinical pharmacology and therapeutics, 36(8), 1998, pp. 418-424

Authors: DOSER K GUSERLE R KRAMER R LAUFER S LICHTENBERGER K

Citation: K. Doser et al., BIOEQUIVALENCE EVALUATION OF 2 FLUTAMIDE PREPARATIONS IN HEALTHY FEMALE SUBJECTS, Arzneimittel-Forschung, 47(2), 1997, pp. 213-217

Authors: DOSER K GUSERLE R NITSCHE V ARNOLD G

Citation: K. Doser et al., COMPARATIVE STEADY-STATE STUDY WITH 2 FENOFIBRATE 250-MG SLOW-RELEASECAPSULES - AN EXAMPLE OF BIOEQUIVALENCE ASSESSMENT WITH A HIGHLY VARIABLE DRUG, International journal of clinical pharmacology and therapeutics, 34(8), 1996, pp. 345-348

Authors: LAUFER S TRIES S AUGUSTIN J ELSASSER R ALBRECHT W GUSERLE R ALGATE DR ATTERSON PR MUNT PL

Citation: S. Laufer et al., ACUTE AND CHRONIC ANTIINFLAMMATORY PROPERTIES OF )-7-PHENYL-2,3-DIHYDRO-1H-PYRROLIZINE-5-YL]-ACETIC ACID, Arzneimittel-Forschung, 45-1(1), 1995, pp. 27-32